Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Clinical trial NCT05004181 · COMPLETED

Trial details

NCT number: NCT05004181
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19 SARS-CoV-2 Acute Respiratory Disease SARS (Disease)

Start date: 2021-08-25
Primary completion: 2023-08-16
Enrollment: 1380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.